
MedTrace Pharma A/S
Primary tabs
About your organization / profile
MedTrace Pharma A/S is a development stage company aiming to innovate PET diagnostic imaging by transforming blood flow quantification. We were founded with the ambition to improve diagnostic accuracy in PET perfusion examinations to the benefit of patients globally. It is our goal to make 15O-water PET (the gold standard perfusion tracer) clinically available globally and to help usher in a new era in diagnostic medicine. MedTrace is currently preparing for a confirmatory multi-center pivotal Phase III trial in cardiology evaluating 15O-water PET versus invasive coronary angiography and current best practice SPECT imaging. The trial will be conducted under an IND with FDA supervision and includes patients from the EU, North America and Japan.
Network (0)
There are no organizations in the network.
Recent activities

MedTrace Pharma A/S is now a member of the EIC ACCESS+ community.

MedTrace Pharma A/S is now a member of the EIC Ecosystem Partnerships and Co-Investment Support Programme community.